Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin and Early Postoperative Cognitive Function in Elderly Spinal Surgery Patients
ChiCTR-IPR-16008931Phase 4Recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of ulinastatin in post-operative cognitive decline (POCD) (2 arms), sponsored by Xuanwu Hospital. Primary endpoints: Lipopolysaccharide (LPS) level, Interleukin-6 (IL-6) level and 2 more. Started Jan 2014; status: recruiting.
02
Drugs
ulinastatin
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR-IPR-16008931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008931.